Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:46 pm Purchase | 13G | Avidity Biosciences Inc. RNA | RA CAPITAL MANAGEMENT L.P. | 6,300,408 5.400% | 1,404,449 (+28.69%) | View |
| 2024-11-14 1:22 pm Purchase | 13G | Avidity Biosciences Inc. RNA | PRICE T ROWE ASSOCIATES INC | 10,633,962 9.000% | 977,110 (+10.12%) | View |
| 2024-11-14 09:39 am Purchase | 13G | Avidity Biosciences Inc. RNA | Avoro Capital Advisors LLC | 9,935,792 8.300% | 9,935,792 (New Position) | View |
| 2024-11-13 4:40 pm Sale | 13G | Avidity Biosciences Inc. RNA | Cowen Financial Products LLC | 0 0.000% | -5,629,103 (Position Closed) | View |
| 2024-11-13 4:05 pm Unchanged | 13G | Avidity Biosciences Inc. RNA | BRISTOL MYERS SQUIBB CO BMY | 5,075,304 4.300% | 0 (Unchanged) | View |
| 2024-11-12 1:26 pm Unchanged | 13G | Avidity Biosciences Inc. RNA | VANGUARD GROUP INC | 9,226,884 7.840% | 0 (Unchanged) | View |
| 2024-11-08 1:56 pm Purchase | 13G | Avidity Biosciences Inc. RNA | WELLINGTON MANAGEMENT GROUP LLP | 7,030,949 5.970% | 7,030,949 (New Position) | View |
| 2024-11-04 10:22 am Purchase | 13G | Avidity Biosciences Inc. RNA | VANGUARD GROUP INC | 9,226,884 7.840% | 5,183,705 (+128.21%) | View |
| 2024-08-23 5:46 pm Purchase | 13D | Avidity Biosciences Inc. RNA | RTW INVESTMENTS LP | 12,079,734 9.990% | 2,419,925 (+25.05%) | View |
| 2024-05-06 5:57 pm Purchase | 13G | Avidity Biosciences Inc. RNA | RA CAPITAL MANAGEMENT L.P. | 4,895,959 5.100% | 2,441,426 (+99.47%) | View |
| 2024-03-11 1:12 pm Purchase | 13G | Avidity Biosciences Inc. RNA | PRICE T ROWE ASSOCIATES INC | 9,656,852 12.100% | 2,738,942 (+39.59%) | View |
| 2024-03-01 4:15 pm Purchase | 13D | Avidity Biosciences Inc. RNA | RTW INVESTMENTS LP | 9,659,809 9.990% | 2,958,320 (+44.14%) | View |
| 2024-02-14 5:01 pm Sale | 13G | Avidity Biosciences Inc. RNA | RA CAPITAL MANAGEMENT L.P. | 2,454,533 3.300% | -3,000,000 (-55.00%) | View |
| 2024-02-14 10:03 am Purchase | 13G | Avidity Biosciences Inc. RNA | PRICE T ROWE ASSOCIATES INC | 6,917,910 9.300% | 210,623 (+3.14%) | View |
| 2024-02-13 4:59 pm Purchase | 13G | Avidity Biosciences Inc. RNA | VANGUARD GROUP INC | 4,043,179 5.460% | 572,553 (+16.50%) | View |
| 2024-02-09 08:35 am Sale | 13G | Avidity Biosciences Inc. RNA | FMR LLC | 10,404,096 14.040% | -218,767 (-2.06%) | View |
| 2024-02-02 12:08 pm Purchase | 13G | Avidity Biosciences Inc. RNA | Cowen Financial Products LLC | 5,629,103 7.600% | 440,737 (+8.49%) | View |
| 2024-01-25 1:48 pm Purchase | 13G | Avidity Biosciences Inc. RNA | BlackRock Inc. BLK | 6,496,593 8.800% | 1,210,419 (+22.90%) | View |
| 2024-01-24 08:13 am Purchase | 13D | Avidity Biosciences Inc. RNA | RTW INVESTMENTS LP | 6,701,489 8.400% | 744,931 (+12.51%) | View |
| 2024-01-23 09:38 am Sale | 13G | Avidity Biosciences Inc. RNA | STATE STREET CORP STT | 3,438,328 4.640% | -131,799 (-3.69%) | View |